Ionis Pharmaceuticals
(IONS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IONS | NBIX | SMMT | ||
| Company | Ionis Pharmaceuticals | Neurocrine Bioscienc | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 84.51 | 136.46 | 14.10 | ||
| High | 86.74 | 141.45 | 14.41 | ||
| Low | 82.89 | 136.46 | 13.83 | ||
| Latest | 83.48 | 137.93 | 13.85 | ||
| Change | -1.51 | +0.07 | -0.57 | ||
| % Change | -1.78% | +0.05% | -3.95% | ||
| Volume | 2,677,700 | 1,272,900 | 3,839,900 | ||
| 20-Day Average Volume | 2,379,930 | 1,078,065 | 3,381,275 | ||
| Previous Close | 84.99 | 137.86 | 14.42 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 81.11 | 135.52 | 16.30 | ||
| 20-Day Raw Stochastic | 74.00% | 71.33% | 0.31% | ||
| 20-Day Relative Strength | 56.97 | 48.11 | 35.48 | ||
| Weighted Alpha | +126.39 | +12.49 | -33.65 | ||
| Today's Opinion | 100% Buy | 8% Buy | 100% Sell | ||
| Previous Opinion | 100% Buy | 8% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 24% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.48% since 01/29/26 | -0.02% since 01/29/26 | -10.06% since 01/29/26 | ||
| Low | 81.90 on 02/02/26 | 134.96 on 01/30/26 | 13.83 on 02/05/26 | ||
| High | 86.74 on 02/05/26 | 141.45 on 02/05/26 | 15.31 on 01/30/26 | ||
| 1-Month | |||||
| %Chg | +6.30% since 01/05/26 | +1.43% since 01/05/26 | -20.58% since 01/05/26 | ||
| Low | 74.20 on 01/20/26 | 129.17 on 01/20/26 | 13.83 on 02/05/26 | ||
| High | 86.74 on 02/05/26 | 142.15 on 01/07/26 | 20.20 on 01/09/26 | ||
| 3-Month | |||||
| %Chg | +11.78% since 11/05/25 | -10.29% since 11/05/25 | -23.35% since 11/05/25 | ||
| Low | 66.66 on 11/10/25 | 129.17 on 01/20/26 | 13.83 on 02/05/26 | ||
| High | 86.74 on 02/05/26 | 160.18 on 12/08/25 | 20.20 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | +93.91% since 08/05/25 | +7.43% since 08/05/25 | -52.45% since 08/05/25 | ||
| Low | 40.03 on 08/07/25 | 123.67 on 08/08/25 | 13.83 on 02/05/26 | ||
| High | 86.74 on 02/05/26 | 160.18 on 12/08/25 | 30.05 on 08/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,521,589 | 13,752,448 | 10,680,429 | ||
| Shares Outstanding, K | 161,974 | 99,706 | 771,150 | ||
| Annual Sales | 705,140,000 | 2,355,300,000 | 0 | ||
| Annual Net Income | -453,900,000 | 341,300,000 | -221,320,000 | ||
| Last Quarter Sales | 156,720,000 | 794,900,000 | 0 | ||
| Last Quarter Net Income | -128,610,000 | 209,500,000 | -231,790,000 | ||
| 60-Month Beta | 0.29 | 0.31 | -1.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.61 on 10/29/25 | 2.04 on 10/28/25 | -0.31 on 10/20/25 | ||
| Latest Earnings Date | 02/18/26 | 02/11/26 | 02/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 32.98 | 0.00 | ||